Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 131.952
Filter
3.
J Nippon Med Sch ; 91(3): 254-260, 2024.
Article in English | MEDLINE | ID: mdl-38972737

ABSTRACT

This review examines associations of nutrients and dietary preferences with recurrent pregnancy loss (RPL), miscarriage, and infertility. Research articles, reviews, and meta-analyses of RPL and infertility that focused on nutrition, meals, and lifestyle were reviewed, and associations of nutrients and dietary preferences with pregnancy are discussed in relation to recent research findings. Studies related to RPL were given the highest priority, followed by those dealing with miscarriage and infertility. Multivitamin supplements-even when lacking folic acid or vitamin A-reduced total fetal loss. High-dose folic acid supplementation before conception reduced the risk of miscarriage and stillbirth. A meta-analysis revealed a strong association of vitamin D deficiency/insufficiency with miscarriage. Another meta-analysis revealed that seafood and dairy products reduced the risk of miscarriage, whereas a caffeine intake of 300 mg/day or more was associated with miscarriage. A balanced diet that included nutrients with antioxidant properties helped prevent miscarriage, whereas a diet that included processed foods and nutrients with proinflammatory effects increased the risk of miscarriage. Associations of nutrients with RPL warrant further research.


Subject(s)
Abortion, Habitual , Diet , Dietary Supplements , Nutrients , Humans , Female , Abortion, Habitual/prevention & control , Abortion, Habitual/etiology , Pregnancy , Nutrients/administration & dosage , Folic Acid/administration & dosage , Infertility/etiology , Life Style , Risk , Antioxidants/administration & dosage , Vitamins/administration & dosage
4.
Allergol Immunopathol (Madr) ; 52(4): 68-72, 2024.
Article in English | MEDLINE | ID: mdl-38970267

ABSTRACT

INTRODUCTION AND OBJECTIVES: Both asthma prevalence and the percentage of cesarean sections have increased in parallel in recent years. Research studies suggest an increased risk of developing atopic diseases and asthma after cesarean section birth compared to vaginal delivery. The main objective of this study is to analyze the risk of asthma admission after cesarean section birth compared to vaginal delivery in the pediatric population. POPULATION AND METHODS: Retrospective observational analytical case-control study from 1993 to 2020. The cases include all admitted patients to our health area hospital, for patients aged 7 to 16 diagnosed with asthma. For each case, a control without a diagnosis of asthma is selected with the same age, and that has also caused an episode of admission. RESULTS: A total of 290 admission episodes with a diagnosis of asthma were obtained, caused by 155 patients. Out of these, 145 cases with documented delivery types were selected. For cases, 155 controls were selected. The historical proportion of cesarean sections in the asthmatic group is 18.6%, compared to 14.2% in the non-asthmatic group. There is a statistically non-significant difference of 4.4% more cesarean sections in the asthmatic group compared to the control group. DISCUSSION: We have not demonstrated a statistically significant association between being born by cesarean section and an increased risk of asthma admission. Based on this finding, we cannot conclude that there is an association between being born by cesarean section and a higher risk of suffering from asthma, unlike what has been postulated in other research studies.


Subject(s)
Asthma , Cesarean Section , Humans , Cesarean Section/statistics & numerical data , Cesarean Section/adverse effects , Asthma/epidemiology , Female , Retrospective Studies , Child , Case-Control Studies , Adolescent , Pregnancy , Male , Risk Factors , Prevalence , Risk
5.
PLoS One ; 19(7): e0288310, 2024.
Article in English | MEDLINE | ID: mdl-38976690

ABSTRACT

This research explores the link between stock markets and banking deposits in South Asian (Pakistan, India, Sri Lanka, Nepal) countries. This study empirically examines the systemic risk potential of financial institutions in South Asia using current systemic risk statistics. Yearly data on stock prices and banking deposits from January 2000 to December 2020 were analyzed using a two-stage process. In the first phase, we measure VaR (value at risk), and in the second step, we measure the DCC GARCH model for our empirical analysis. The study findings reveal systemic risk spillover between the stock markets of South Asian countries and the relevant country's banking system deposits. The policymakers can use our study findings to create a more sustainable financial sector.


Subject(s)
Investments , Investments/economics , Humans , India , Sri Lanka , Nepal , Commerce/economics , Models, Economic , Pakistan , Banking, Personal , Risk , Asia
9.
Science ; 384(6701): 1159-1160, 2024 Jun 14.
Article in English | MEDLINE | ID: mdl-38870298

ABSTRACT

New studies include health data collected from space tourists on first privately funded orbital mission.


Subject(s)
Astronauts , Space Flight , Humans , Risk
10.
Article in English | MEDLINE | ID: mdl-38847554

ABSTRACT

The aim of the present study was to determine the associations between the MICB genetic variability and the expression and the risk of development of post-transplant complications after allogeneic hematopoietic stem cell transplantation (HSCT). HSCT recipients and their donors were genotyped for two MICB polymorphisms (rs1065075, rs3828903). Moreover, the expression of a soluble form of MICB was determined in the recipients' serum samples after transplantation using the Luminex assay. Our results revealed a favorable role of the MICB rs1065075 G allele. Recipients with donors carrying this genetic variant were less prone to developing chronic graft-versus-host disease (cGvHD) when compared to recipients without any symptoms of this disease (41.41% vs. 65.38%, p = 0.046). Moreover, the MICB rs1065075 G allele was associated with a lower incidence of cytomegalovirus (CMV) reactivation, both as a donor (p = 0.015) and as a recipient allele (p = 0.039). The MICB rs1065075 G variant was also found to be associated with decreased serum soluble MICB (sMICB) levels, whereas serum sMICB levels were significantly higher in recipients diagnosed with CMV infection (p = 0.0386) and cGvHD (p = 0.0008) compared to recipients without those complications. A protective role of the G allele was also observed for the rs3828903 polymorphism, as it was more frequently detected among donors of recipients without cGvHD (89.90% vs. 69.23%; p = 0.013). MICB genetic variants, as well as serum levels of sMICB, may serve as prognostic factors for the risk of developing cGvHD and CMV infection after allogeneic HSCT.


Subject(s)
Cytomegalovirus Infections , Genetic Predisposition to Disease , Graft vs Host Disease , Hematopoietic Stem Cell Transplantation , Minor Histocompatibility Antigens , Transplantation, Homologous , Humans , Graft vs Host Disease/genetics , Graft vs Host Disease/etiology , Cytomegalovirus Infections/genetics , Hematopoietic Stem Cell Transplantation/adverse effects , Male , Female , Transplantation, Homologous/adverse effects , Adult , Middle Aged , Chronic Disease , Minor Histocompatibility Antigens/genetics , Histocompatibility Antigens Class I/genetics , Polymorphism, Single Nucleotide , Alleles , Genotype , Young Adult , Cytomegalovirus/physiology , Adolescent , Risk , Risk Factors
11.
Expert Rev Anticancer Ther ; 24(7): 623-633, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38879826

ABSTRACT

INTRODUCTION: Combinations of immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs) can be responsible for major adverse cardiovascular events (MACEs). We performed a meta-analysis to assess the relative risk (RR) of MACEs and hypertension in cancer patients treated with ICI+TKI combinations. RESEARCH DESIGN AND METHODS: We selected prospective trials through MEDLINE/PubMed, Cochrane Library, and ASCOMeeting abstracts. We calculated combined ORs, RRs, and 95% CIs using RevMansoftware for meta-analysis (v.5.2.3). RESULTS: Seven studies were selected for the analysis of MACEs (3849 patients). The incidence MACEs were 0.8% with ICI+TKI combinations, compared to 0.2% in the control arms for both any- and high-grade. ICI+TKI combinations significantly increased the risk of any- (OR = 3.21; p = 0.01) and high-grade MACEs (OR = 2.72; p = 0.05). Ten studies were selected for the analysis of hypertension (5744 patients). The incidence of treatment-related hypertension of any-grade and high-grade was41.3% (vs. 20.8%) and 26.1% (vs. 12.3%) with ICI+TKI combinations, respectively. ICI+TKI combinations significantly increased the risk of treatment-related hypertension of any-grade (RR = 2.10; p = 0.001), but not of high-grade (p = 0.11). CONCLUSIONS: ICI+TKI combinations increase the risk of MACEs compared to controls, although the absolute incidence is eventually low. Routine cardiovascular monitoring in asymptomatic patients is therefore not recommended.


Subject(s)
Cardiovascular Diseases , Hypertension , Immune Checkpoint Inhibitors , Neoplasms , Protein Kinase Inhibitors , Humans , Immune Checkpoint Inhibitors/adverse effects , Immune Checkpoint Inhibitors/administration & dosage , Neoplasms/drug therapy , Incidence , Hypertension/chemically induced , Hypertension/epidemiology , Protein Kinase Inhibitors/adverse effects , Protein Kinase Inhibitors/administration & dosage , Cardiovascular Diseases/chemically induced , Cardiovascular Diseases/epidemiology , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Risk
15.
Respir Investig ; 62(4): 710-716, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38823190

ABSTRACT

The number of older people with impaired swallowing function increases with aging population. Aspiration pneumonia is one of the most cases of pneumonia developing among older people. As aspiration pneumonia may develop as a result of age-related deterioration, it is crucial to consider it as an unavoidable event with aging. While pneumonia is diagnosed based on respiratory symptoms and radiological features, the lung involvement of aspiration pneumonia may be undetectable via a frontal chest radiograph in some cases. Bacterial profiles show the predominance of drug-resistant bacteria, such as Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA), but isolated bacteria from respiratory samples do not necessarily indicate causative pathogens. Furthermore, there is no evidence regarding treatment superiority using broad-spectrum antibiotics compared with narrow-spectrum antibiotics. Even if isolated pathogens are a causative factor for pneumonia among older patients, the use of broad-spectrum antibiotics covering the bacteria may not improve their outcomes. Therefore, we propose a treatment strategy independent of the risk of drug resistance focusing on the discrimination of patients who are unlikely to respond to broad-spectrum antibiotics. An aspiration risk is associated with increased in-hospital mortality in patients with pneumonia, which could also lead to a greater risk of poor long-term outcomes with increased 1-year mortality. Advance care planning is now recognized as a process for communication and medical decision-making across the life course. This approach would be widely recommended for older people with aspiration risk.


Subject(s)
Anti-Bacterial Agents , Pneumonia, Aspiration , Humans , Aged , Anti-Bacterial Agents/therapeutic use , Pneumonia, Aspiration/drug therapy , Pneumonia, Aspiration/microbiology , Pneumonia, Aspiration/etiology , Drug Resistance, Bacterial , Risk , Longevity , Aged, 80 and over , Pneumonia/drug therapy , Pneumonia/microbiology , Hospital Mortality , Methicillin-Resistant Staphylococcus aureus/drug effects
16.
Sci Rep ; 14(1): 10460, 2024 05 07.
Article in English | MEDLINE | ID: mdl-38714713

ABSTRACT

While autonomous artificial agents are assumed to perfectly execute the strategies they are programmed with, humans who design them may make mistakes. These mistakes may lead to a misalignment between the humans' intended goals and their agents' observed behavior, a problem of value alignment. Such an alignment problem may have particularly strong consequences when these autonomous systems are used in social contexts that involve some form of collective risk. By means of an evolutionary game theoretical model, we investigate whether errors in the configuration of artificial agents change the outcome of a collective-risk dilemma, in comparison to a scenario with no delegation. Delegation is here distinguished from no-delegation simply by the moment at which a mistake occurs: either when programming/choosing the agent (in case of delegation) or when executing the actions at each round of the game (in case of no-delegation). We find that, while errors decrease success rate, it is better to delegate and commit to a somewhat flawed strategy, perfectly executed by an autonomous agent, than to commit execution errors directly. Our model also shows that in the long-term, delegation strategies should be favored over no-delegation, if given the choice.


Subject(s)
Game Theory , Humans , Models, Theoretical , Risk
17.
Biometrics ; 80(2)2024 Mar 27.
Article in English | MEDLINE | ID: mdl-38742906

ABSTRACT

Semicompeting risks refer to the phenomenon that the terminal event (such as death) can censor the nonterminal event (such as disease progression) but not vice versa. The treatment effect on the terminal event can be delivered either directly following the treatment or indirectly through the nonterminal event. We consider 2 strategies to decompose the total effect into a direct effect and an indirect effect under the framework of mediation analysis in completely randomized experiments by adjusting the prevalence and hazard of nonterminal events, respectively. They require slightly different assumptions on cross-world quantities to achieve identifiability. We establish asymptotic properties for the estimated counterfactual cumulative incidences and decomposed treatment effects. We illustrate the subtle difference between these 2 decompositions through simulation studies and two real-data applications in the Supplementary Materials.


Subject(s)
Computer Simulation , Humans , Models, Statistical , Risk , Randomized Controlled Trials as Topic/statistics & numerical data , Mediation Analysis , Treatment Outcome , Biometry/methods
18.
Expert Rev Anticancer Ther ; 24(7): 485-491, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38712572

ABSTRACT

INTRODUCTION: The link between talcum powder use and cancer, particularly ovarian cancer, has been a topic of scientific research and legal debate for several years. Studies have suggested a potential association between long-term talcum powder use in the genital area and an increased risk of ovarian cancer. AREAS COVERED: The following report includes up-to-date evidence to support the potential link between talcum powder use and the risk of developing ovarian cancer. The International Agency for Research on Cancer, which is part of the World Health Organization, classified talc-based body powder as possibly carcinogenic to humans when used in the female genital area. However, other studies have not consistently supported this association, and thus more research is needed to establish a clear and definitive link between talcum powder use and cancer. Despite this, recent molecular-level data have linked talc to alterations in redox balance, gene mutations, and inflammatory responses. Specifically, we have identified a role for talc to induce the pro-oxidant state, inhibit apoptosis, and more importantly induced cellular transformation in normal ovarian cells. EXPERT OPINION: We presented unequivocal evidence to support our opinion that talc is not biologically inert and induces molecular changes that mimic the hallmarks of cancer.


Subject(s)
Ovarian Neoplasms , Oxidative Stress , Talc , Talc/adverse effects , Talc/administration & dosage , Humans , Female , Ovarian Neoplasms/pathology , Animals , Apoptosis , Powders , Cell Transformation, Neoplastic/chemically induced , Risk , Carcinogens/toxicity
20.
JAMA ; 331(23): 1985-1986, 2024 06 18.
Article in English | MEDLINE | ID: mdl-38709521

ABSTRACT

This Viewpoint discusses how data gaps in published research impede clinicians' ability to clearly discuss the risks and benefits of amyloid-lowering drugs for treating Alzheimer disease.


Subject(s)
Alzheimer Disease , Amyloid beta-Peptides , Antibodies, Monoclonal, Humanized , Humans , Alzheimer Disease/drug therapy , Antibodies, Monoclonal, Humanized/adverse effects , Antibodies, Monoclonal, Humanized/therapeutic use , Risk , Clinical Trials as Topic
SELECTION OF CITATIONS
SEARCH DETAIL
...